231 related articles for article (PubMed ID: 24202136)
1. Body fat content and distribution and urinary risk factors for nephrolithiasis.
Pigna F; Sakhaee K; Adams-Huet B; Maalouf NM
Clin J Am Soc Nephrol; 2014 Jan; 9(1):159-65. PubMed ID: 24202136
[TBL] [Abstract][Full Text] [Related]
2. Net Acid Excretion and Urinary Organic Anions in Idiopathic Uric Acid Nephrolithiasis.
Bobulescu IA; Park SK; Xu LHR; Blanco F; Poindexter J; Adams-Huet B; Davidson TL; Sakhaee K; Maalouf NM; Moe OW
Clin J Am Soc Nephrol; 2019 Mar; 14(3):411-420. PubMed ID: 30745301
[TBL] [Abstract][Full Text] [Related]
3. Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
Otto BJ; Bozorgmehri S; Kuo J; Canales M; Bird VG; Canales B
J Endourol; 2017 Dec; 31(12):1335-1341. PubMed ID: 29084490
[TBL] [Abstract][Full Text] [Related]
4. Relationship between body mass index and quantitative 24-hour urine chemistries in patients with nephrolithiasis.
Eisner BH; Eisenberg ML; Stoller ML
Urology; 2010 Jun; 75(6):1289-93. PubMed ID: 20018350
[TBL] [Abstract][Full Text] [Related]
5. Urinary Lithogenic Risk Profile in ADPKD Patients Treated with Tolvaptan.
Bargagli M; Dhayat NA; Anderegg M; Semmo M; Huynh-Do U; Vogt B; Ferraro PM; Fuster DG
Clin J Am Soc Nephrol; 2020 Jul; 15(7):1007-1014. PubMed ID: 32527945
[TBL] [Abstract][Full Text] [Related]
6. Can 24-hour urine stone risk profiles predict urinary stone composition?
Torricelli FC; De S; Liu X; Calle J; Gebreselassie S; Monga M
J Endourol; 2014 Jun; 28(6):735-8. PubMed ID: 24460026
[TBL] [Abstract][Full Text] [Related]
7. Body size and 24-hour urine composition.
Taylor EN; Curhan GC
Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
[TBL] [Abstract][Full Text] [Related]
8. Idiopathic recurrent calcium urolithiasis (IRCU): variation of fasting urinary protein is a window to pathophysiology or simple consequence of renal stones in situ? A tripartite study in male patients providing insight into oxidative metabolism as possible driving force towards alteration of urine composition, calcium salt crystallization and stone formation.
Schwille PO; Schmiedl A; Wipplinger J
Eur J Med Res; 2009 Sep; 14(9):378-92. PubMed ID: 19748857
[TBL] [Abstract][Full Text] [Related]
9. Treatment of calcium nephrolithiasis in the patient with hyperuricosuria.
Arowojolu O; Goldfarb DS
J Nephrol; 2014 Dec; 27(6):601-5. PubMed ID: 24687403
[TBL] [Abstract][Full Text] [Related]
10. Re: body fat content and distribution and urinary risk factors for nephrolithiasis.
Assimos DG
J Urol; 2014 Jun; 191(6):1811. PubMed ID: 25280290
[No Abstract] [Full Text] [Related]
11. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
12. Factors increasing the risk for stone formation in adult patients with cystic fibrosis.
Terribile M; Capuano M; Cangiano G; Carnovale V; Ferrara P; Petrarulo M; Marangella M
Nephrol Dial Transplant; 2006 Jul; 21(7):1870-5. PubMed ID: 16595587
[TBL] [Abstract][Full Text] [Related]
13. Clinical and biochemical profile of patients with "pure" uric acid nephrolithiasis compared with "pure" calcium oxalate stone formers.
Negri AL; Spivacow R; Del Valle E; Pinduli I; Marino A; Fradinger E; Zanchetta JR
Urol Res; 2007 Oct; 35(5):247-51. PubMed ID: 17786420
[TBL] [Abstract][Full Text] [Related]
14. Age-related changes in 24-hour urine composition must be considered in the medical management of nephrolithiasis.
Friedlander JI; Moreira DM; Hartman C; Elsamra SE; Smith AD; Okeke Z
J Endourol; 2014 Jul; 28(7):871-6. PubMed ID: 24571654
[TBL] [Abstract][Full Text] [Related]
15. Urinary Risk Profile, Impact of Diet, and Risk of Calcium Oxalate Urolithiasis in Idiopathic Uric Acid Stone Disease.
Siener R; Löhr P; Hesse A
Nutrients; 2023 Jan; 15(3):. PubMed ID: 36771279
[TBL] [Abstract][Full Text] [Related]
16. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance.
Abate N; Chandalia M; Cabo-Chan AV; Moe OW; Sakhaee K
Kidney Int; 2004 Feb; 65(2):386-92. PubMed ID: 14717908
[TBL] [Abstract][Full Text] [Related]
17. Clinical and metabolic evaluation of patients with history of renal calculi in Qazvin, Iran.
Charkhchian M; Samani S; Merat E
Ir J Med Sci; 2015 Dec; 184(4):731-5. PubMed ID: 24923966
[TBL] [Abstract][Full Text] [Related]
18. Metabolic basis for low urine pH in type 2 diabetes.
Maalouf NM; Cameron MA; Moe OW; Sakhaee K
Clin J Am Soc Nephrol; 2010 Jul; 5(7):1277-81. PubMed ID: 20413437
[TBL] [Abstract][Full Text] [Related]
19. Association of Body Mass Index, Waist Circumference, and Waist-Stature Ratio With Urine Composition in Patients With Urolithiasis.
Tavasoli S; Taheri M; Khoshdel A; Basiri A
Iran J Kidney Dis; 2017 Oct; 11(5):371-378. PubMed ID: 29038393
[TBL] [Abstract][Full Text] [Related]
20. Influence of BMI in nephrolithiasis in an Appalachian pediatric population: A single-center experience.
Murphy MO; Erpelding SG; Chishti AS; Dugan A; Ziada A; Kiessling SG
J Pediatr Urol; 2018 Aug; 14(4):330.e1-330.e8. PubMed ID: 29887297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
